Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 Settembre;52(3) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 Settembre;52(3):215-21

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


eTOC

 

REVIEWS  AN OVERVIEW OF THE RADIOPHARMACOLOGY FIELD TO DATE


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 Settembre;52(3):215-21

lingua: Inglese

Small animal PET in preclinical studies: opportunities and challenges

Riemann B., Schäfers K. P., Schober O., Schäfers M.

Department of Nuclear Medicine University Hospital, Münster, Germany


FULL TEXT  


The process of drug and molecular imaging development is strongly influenced by the revolution of non-invasive imaging techniques. Small animal positron emission tomography (PET) has the potential to accelerate and streamline drug and molecular imaging discovery and development by preselection of suitable candidate molecules. Due to its significantly improved spatial resolution and its quantitative nature, compared to other techniques small animal PET can be employed to bridge the in vitro, through to preclinical and clinical imaging in humans.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail